Stem cell-derived exosomes inhaled for pneumonitis from cancer immunotherapy
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests whether inhaled exosomes (tiny particles derived from stem cells) can help repair lung damage caused by immune checkpoint inhibitor therapy—a common cancer treatment. You would qualify if you developed serious lung inflammation from this therapy that hasn't fully healed with standard steroid treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 with a confirmed cancer diagnosis
- Received at least one immune checkpoint inhibitor drug (common cancer immunotherapy)
- Developed serious lung inflammation (Grade 3–4) from that drug
- Took steroids for at least 4 weeks and now take low or no steroids
- Recent lung imaging shows ongoing inflammation in both lungs that hasn't improved in the last month
- Good overall health (ECOG score 0–1) and stable cancer for at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new treatment using extracts from human umbilical cord stem cells, given by inhalation, to see if it is safe and can help patients with interstitial lung disease (a condition where lung tissue becomes scarred and stiff). The study will measure whether this approach reduces symptoms and improves how well your lungs work.
This trial tests if inhaled particles from stem cells (called exosomes) can help with a cough that lasts 3-8 weeks after a cold or flu. It may be an option if your chest X-ray is normal and other causes of cough have been ruled out.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests a new inhaled treatment made from placental stem cells to see if it's safe and helps slow scarring in the lungs (idiopathic pulmonary fibrosis). The treatment is breathed in through a nebulizer, similar to an asthma inhaler.
This early-phase trial tests if stem cells from donated umbilical cords can help people with interstitial lung disease. It's designed for people whose lung function is moderately reduced and who haven't tried stem cell therapy before.
This trial tests whether using an inhaled steroid (budesonide) can help prevent lung inflammation (pneumonitis) from coming back in people who have had it caused by immunotherapy cancer treatment. It may be an option for patients who need extra support after their first bout of this side effect.
Hear when a new Immune Checkpoint Inhibitors (ICIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.